Private Advisor Group’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-89
Closed -$11.8K 2436
2023
Q3
$11.8K Sell
89
-1
-1% -$155 ﹤0.01% 2159
2023
Q2
$16.4K Hold
90
﹤0.01% 1995
2023
Q1
$15.1K Hold
90
﹤0.01% 1935
2022
Q4
$19 Sell
90
-1
-1% -$378 ﹤0.01% 1644
2022
Q3
$35K Sell
91
-1
-1% -$567 ﹤0.01% 1854
2022
Q2
$39K Buy
92
+21
+30% +$10.1K ﹤0.01% 2027
2022
Q1
$42K Buy
71
+21
+42% +$15.6K ﹤0.01% 2046
2021
Q4
$56K Sell
50
-15
-23% -$32.6K ﹤0.01% 2071
2021
Q3
$251K Buy
65
+19
+41% +$59.9K ﹤0.01% 1778
2021
Q2
$134K Buy
46
+15
+48% +$35.4K ﹤0.01% 1883
2021
Q1
$62K Sell
31
-12
-28% -$18K ﹤0.01% 1837
2020
Q4
$41K Hold
43
﹤0.01% 1730
2020
Q3
$34K Hold
43
﹤0.01% 1525
2020
Q2
$40K Buy
43
+21
+95% +$21K ﹤0.01% 2221
2020
Q1
$20K Sell
22
-22
-50% -$18K ﹤0.01% 1392
2019
Q4
$24K Hold
44
﹤0.01% 1604
2019
Q3
$19K Buy
44
+5
+13% +$2.28K ﹤0.01% 1636
2019
Q2
$20K Buy
39
+17
+77% +$8.98K ﹤0.01% 1649
2019
Q1
$11K Buy
+22
New +$10.1K ﹤0.01% 1533

Other funds holding PAVM

Private Advisor Group's PAVM Position: Q4 2023 in Review

Private Advisor Group sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 89 shares — an estimated $11.8K sold.

Private Advisor Group first reported a position in PAVM in Q1 2019 and held it in 19 quarters. The position peaked at $251K in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Private Advisor Group reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Private Advisor Group sold 89 PAVmed shares in Q4 2023, an estimated $11.8K.
  • Private Advisor Group first reported a position in PAVmed in Q1 2019 and held it in 19 quarters.
  • Private Advisor Group's PAVmed position peaked at $251K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Private Advisor Group's 13F filing for Q4 2023, filed 6 Feb 2024.